4th March 2022
- 0 comments
Our member and University of Bristol spin-out, FluoretiQ, has today announced the completion of a £1.1 million, pre-series A investment. Their pioneering NANOPLEX technology is a 15-minute proprietary diagnostic platform for bacterial infections.
In order to read the full story we need you to be registered with us, please click the links below to login or register.